Acciones de biotecnología: análisis y clasificaciones de IA
Esta página fue traducida automáticamente del original en inglés mediante IA; la versión en inglés es la autorizada. Leer la versión en inglés
Respuesta Rápida
Explore todas las acciones de biotecnología con análisis impulsado por IA, MoonshotScores y objetivos de precios.
Explore todas las acciones de biotecnología con análisis impulsado por IA, MoonshotScores y objetivos de precios.
Acciones relacionadas en Biotecnología
| Empresa | Precio | Cambio | Capitalización de Mercado | MoonshotScore |
|---|---|---|---|---|
| EXEL Exelixis, Inc. | $58.39 | +0.78% | $14.7B | — |
| HRMY Harmony Biosciences Holdings, Inc. | $39.64 | +0.18% | $2.29B | — |
| INCY Incyte Corporation | $115.30 | -1.57% | $23.4B | — |
| ARGX argenx SE | $919.21 | -1.79% | $57.2B | — |
| AUPH Aurinia Pharmaceuticals Inc. | $15.83 | -0.75% | $2.04B | — |
| ETON Eton Pharmaceuticals, Inc. | $55.36 | +6.50% | $1.52B | — |
| KRYS Krystal Biotech, Inc. | $322.28 | -0.93% | $9.54B | — |
| UTHR United Therapeutics Corporation | $541.70 | -5.19% | $23.0B | — |
| VRTX Vertex Pharmaceuticals Incorporated | $504.73 | -0.40% | $128B | — |
| LGND Ligand Pharmaceuticals Incorporated | $302.96 | +0.07% | $6.07B | — |
| VCYT Veracyte, Inc. | $45.81 | +3.67% | $3.66B | — |
| TBPH Theravance Biopharma, Inc. | $17.03 | — | $883M | — |
| ADMA ADMA Biologics, Inc. | $9.72 | -2.11% | $2.25B | — |
| CRMD CorMedix Inc. | $7.19 | -3.10% | $564M | — |
| REGN Regeneron Pharmaceuticals, Inc. | $735.20 | +0.05% | $75.7B | — |
| RIGL Rigel Pharmaceuticals, Inc. | $47.15 | +0.38% | $872M | — |
| TECH Bio-Techne Corporation | $72.40 | — | $11.3B | — |
| LQDA Liquidia Corporation | $28.64 | +2.32% | $2.55B | — |
| VCEL Vericel Corporation | $40.15 | +1.80% | $2.06B | — |
| CORT Corcept Therapeutics Incorporated | $116.23 | +1.93% | $12.6B | — |
| NVO Novo Nordisk A/S | $37.32 | -0.21% | $166B | — |
| ZVRA Zevra Therapeutics, Inc. | $9.99 | -1.87% | $591M | — |
| INVA Innoviva, Inc. | $20.50 | -0.24% | $1.51B | — |
| NBIX Neurocrine Biosciences, Inc. | $143.18 | +1.76% | $14.4B | — |
| ALNY Alnylam Pharmaceuticals, Inc. | $219.72 | -4.96% | $29.4B | — |
| CAI Caris Life Sciences, Inc. | $28.30 | -0.18% | $8.00B | — |
| ARQT Arcutis Biotherapeutics, Inc. | $25.16 | -0.51% | $3.15B | — |
| ASND Ascendis Pharma A/S | $227.87 | +0.25% | $14.2B | — |
| HALO Halozyme Therapeutics, Inc. | $109.86 | +2.73% | $13.0B | — |
| MDXG MiMedx Group, Inc. | $4.59 | -1.08% | $669M | — |
| ABUS Arbutus Biopharma Corporation | $4.45 | -2.41% | $879M | — |
| RLYB Rallybio Corporation | $17.08 | +1.91% | $90.6M | — |
| ANAB AnaptysBio, Inc. | $48.53 | -0.21% | $1.44B | — |
| ICCC ImmuCell Corporation | $9.75 | +1.56% | $88.2M | — |
| PHAR Pharming Group N.V. | $9.75 | -2.01% | $690M | — |
| ACAD ACADIA Pharmaceuticals Inc. | $19.95 | +0.30% | $3.42B | — |
| ORMP Oramed Pharmaceuticals Inc. | $4.49 | +0.22% | $184M | — |
| PTGX Protagonist Therapeutics, Inc. | $140.06 | +0.63% | $9.01B | — |
| ELVN Enliven Therapeutics, Inc. | $46.97 | +1.64% | $3.36B | — |
| RPRX Royalty Pharma plc | $57.16 | -0.82% | $25.3B | — |
| MBX MBX Biosciences | $58.51 | +3.47% | $2.78B | — |
| BLTE Belite Bio, Inc. | $159.56 | -2.10% | $6.40B | — |
| LBRX LB Pharmaceuticals Inc | $36.99 | -0.78% | $1.06B | — |
| NAGE Niagen Bioscience Inc | $2.79 | +4.10% | $222M | — |
| CLYM Climb Bio, Inc. | $10.94 | -1.17% | $626M | — |
| ORKA Oruka Therapeutics, Inc. | $84.52 | +1.32% | $5.10B | — |
| ANTX AN2 Therapeutics, Inc. | $5.71 | +1.60% | $206M | — |
| QTTB Q32 Bio Inc. | $8.23 | -0.24% | $245M | — |
| AMLX Amylyx Pharmaceuticals, Inc. | $27.79 | -1.03% | $3.09B | — |
| EWTX Edgewise Therapeutics, Inc. | $41.40 | +2.27% | $4.45B | — |
Puntuación IA por Stock Expert AI · Datos de precio: FMP / Yahoo Finance